AI Innovators with Global Expertise

Since launching as a spin-out from the University of Oxford, Brainomix has revolutionized medical imaging with an AI-powered platform that automates validated imaging biomarkers—improving both diagnosis and treatment decisions.

Our Brainomix 360 Stroke platform is the most comprehensive stroke imaging solution available, trusted by healthcare systems worldwide to drive better patient outcomes.

Building on this legacy, we are expanding beyond stroke into new therapeutic areas with similar unmet needs—harnessing AI to transform diagnosis and treatment where it matters most.

Born in Oxford

As a spinout from the University of Oxford, Brainomix is built on a foundation of scientific excellence and a commitment to innovation. Our world-class team is at the forefront of AI-driven imaging advancements, continually pushing the boundaries of what’s possible in healthcare.

"In terms of the future, we are seeing that AI is transforming healthcare and we are part of this wave. With what we are doing now, we are seeing impact on a daily basis,"

— Dr. Michalis Papadakis, CEO & Co-Founder, Brainomix

Get in touch to discover how our pioneering AI solutions are shaping the future of medical imaging.

Let's Talk AI

Value-Generating Partnerships

Over the years, Brainomix has formed a number of key partnerships that have enabled us to broaden our reach, expand our portfolio, and deliver innovative, end-to-end solutions to customers.

We focus on creating value-generating partnerships that can improve clinical trial success and foster broad adoption of existing therapies in stroke, lung fibrosis and cancer.

Learn more

Expanding Access to Life-Saving Treatments

At Brainomix, we are dedicated to harnessing AI to transform patient care and improve outcomes.

Meet Margaret, a stroke survivor from Milton Keynes whose swift diagnosis, transfer, and treatment were made possible with Brainomix technology. Her story is a powerful example of how innovation is saving lives every day.